User: Guest  Login
Document type:
journal article 
Author(s):
Ndrepepa, G; Kastrati, A; Mehilli, J; Neumann, FJ; ten Berg, J; Bruskina, O; Dotzer, F; Seyfarth, M; Pache, J; Dirschinger, J; Berger, PB; Schömig, A 
Title:
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial. 
Abstract:
AIMS: The aim of this study is to investigate whether the benefit of abciximab in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACSs) undergoing percutaneous coronary intervention (PCI) after pre-treatment with 600 mg clopidogrel is sustained at 1 year. METHODS AND RESULTS: We performed 1-year follow-up of 2022 high-risk patients with NSTE-ACS undergoing urgent PCI, who were randomized to abciximab or placebo after pre-treatment with 600 mg clopidogrel in the Intracoronar...    »
 
Journal title abbreviation:
Eur Heart J 
Year:
2008 
Journal volume:
29 
Journal issue:
Pages contribution:
455-61 
Language:
eng 
Print-ISSN:
0195-668X 
TUM Institution:
I. Medizinische Klinik und Poliklinik